HDFC Securities expects Aurobindo Pharma to touch Rs 760 News News / News 6 years ago 520 Views comments Aurobindo Pharma gains ahead of US Food and Drug Administration (US FDA) target action date for Renvela generic. In an interview to CNBC-TV18, Amey Ch... Read more
News Shift to commerce ministry from railways no demotion, says Suresh Prabhu News / News - 6 years ago
Comments